We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Metabolite Drug Tackles Multiple Sclerosis by Altering T Cells' Epigenetic Landscape

News   Mar 01, 2019 | Original Press Release from the Advanced Science Research Center at the Graduate Center of the City University of New York

 
Metabolite Drug Tackles Multiple Sclerosis by Altering T Cells' Epigenetic Landscape

Fumaric Acid Ester Metabolites act as a regulator of the micro RNA MIR-21, which is necessary to create the brain-homing T cells that are active in multiple sclerosis. Credit: Carter Eitreim

 
 
 

RELATED ARTICLES

"Undetectable Equals Untransmittable" Now the Accepted HIV Message

News

People living with HIV who achieve and maintain an undetectable viral load by taking antiretroviral therapy as prescribed do not sexually transmit HIV to others. The U.S. Centers for Disease Control and Prevention estimates this strategy is 100% effective against the sexual transmission of HIV.

READ MORE

Open Source EEG Tool Hopes To Tackle Opioid Use

News

Researchers have developed an open source computer program that can be used to create visual and quantitative representations of brain electrical activity in laboratory animals, in hopes of tackling opioid use.

READ MORE

"Invisible Sight" Reveals Secrets of Vision

News

Researchers have found evidence supporting two-photon vision, a phenomenon which could be useful for examination of the eye.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics Genomics Research Neuroscience Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE